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Background
In severe aortic stenosis (AS), hemodynamics and conventional indices do not fully explain symptoms, prognosis or treatment response. We hypothesize that diffuse myocardial fibrosis (DMF) is a key missing factor in AS. This can now be accurately measured non-invasively using equilibrium contrast CMR (EQ-CMR) [1] involving a primed gadolinium infusion, T1 measurement pre-and post-infusion, and direct measure of blood volume of distribution (1-hematocrit). The derived myocardial volume of distribution (Vd (m) ) correlates strongly with histological diffuse myocardial fibrosisin AS and this calibration can convert Vd (m) to DMF%. Cell volume can be calculated as 1-DMF%*LV mass.
Methods
63 severe AS patients with planned valve replacement underwent baseline and follow up EQ-CMR. Twenty normal controls were included. Baseline and follow-up assessment included NYHA, ECG, echocardiography (for diastolic function and valve area/velocities), BNP and six minute walk test (6MWT). Follow up was at 6-months (2 declined, 4 late deaths, 13 pacemakers,
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The Heart Hospital, London, UK Full list of author information is available at the end of the article DMF correlated with 6MWT (inversely, figure 1, r 2 =0.22, p=0.001) and aortic valve area (r 2 =0.21, p=0.001). DMF only correlated with EF in patients with LV impairment (n=15, r 2 =0.47, p=0.01). Severe DMF patients had worse diastolic function (p=0.029). In a multivariate analysis of all parameters classically associated with 6MWT distance, the only independent predictor was DMF (p=0.04). On univariate analysis there was a weak correlation with BNP and age.
Follow up
Overall, patients improved at follow-up (6MWT, EF, BNP, LV mass, LV volumes). However, only patients with severe fibrosis improved their exercise capacity (p=0.03). LVH regression (202g vs 183g, p=0.002) was shown to be cellular (161g vs. 142g, p<0.001) rather than fibrosis (36g vs 34g p=0.572) resolution, figure 2.
Conclusion
In this first clinical EQ-CMR study of severe AS, DMF is higher when there is LV impairment, diastolic dysfunction and more severe stenosis. DMF is the single best predictor of pre-op exercise capacity and post-op improvement. EQ-CMR shows that at 6-month post valve replacement LVH regression is predominantly reduced cell rather than fibrosis volume. EQ-CMR for the non-invasive measurement of DMF appears to be a significant cardiological advance.
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